Federated Hermes’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.88M | Buy |
42,743
+29,962
| +234% | +$4.12M | 0.01% | 691 |
|
2025
Q1 | $2.3M | Sell |
12,781
-267
| -2% | -$48.1K | 0.01% | 903 |
|
2024
Q4 | $2.04M | Buy |
13,048
+229
| +2% | +$35.9K | ﹤0.01% | 927 |
|
2024
Q3 | $2.33M | Buy |
+12,819
| New | +$2.33M | 0.01% | 898 |
|
2023
Q4 | – | Sell |
-5
| Closed | -$580 | – | 2121 |
|
2023
Q3 | $580 | Hold |
5
| – | – | ﹤0.01% | 2034 |
|
2023
Q2 | $587 | Hold |
5
| – | – | ﹤0.01% | 2047 |
|
2023
Q1 | $400 | Sell |
5
-1
| -17% | -$80 | ﹤0.01% | 2084 |
|
2022
Q4 | $475 | Hold |
6
| – | – | ﹤0.01% | 2086 |
|
2022
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 2051 |
|
2022
Q2 | $1K | Hold |
6
| – | – | ﹤0.01% | 2050 |
|
2022
Q1 | $1K | Sell |
6
-654
| -99% | -$109K | ﹤0.01% | 2097 |
|
2021
Q4 | $46K | Sell |
660
-7,451
| -92% | -$519K | ﹤0.01% | 1798 |
|
2021
Q3 | $423K | Sell |
8,111
-145,503
| -95% | -$7.59M | ﹤0.01% | 1542 |
|
2021
Q2 | $10.4M | Buy |
153,614
+19,623
| +15% | +$1.33M | 0.02% | 642 |
|
2021
Q1 | $10.3M | Buy |
+133,991
| New | +$10.3M | 0.02% | 652 |
|
2019
Q2 | – | Sell |
-124
| Closed | -$4K | – | 2191 |
|
2019
Q1 | $4K | Sell |
124
-834
| -87% | -$26.9K | ﹤0.01% | 1999 |
|
2018
Q4 | $20K | Hold |
958
| – | – | ﹤0.01% | 1770 |
|
2018
Q3 | $17K | Buy |
+958
| New | +$17K | ﹤0.01% | 1867 |
|